Researchers reported that those subjects with past cannabis exposure possessed slightly lower odds of AKI (OR 0.85) than did those with no exposure
22 percent affirmed having provided CBD to a child on the autism spectrum. Seventy-two percent of all respondents were parents while the remaining 28 percent were caregivers.
Those who consume cannabis and/or cannabis preparations high in the cannabinoid cannabigerol (CBG) say that they are effective therapeutics and that they possess few adverse side-effects, according to data published in the journal Cannabis and Cannabinoid Research.
Patients diagnosed with fibromyalgia and other inflammatory rheumatic diseases report experiencing reduced levels of pain and improved sleep quality following their use of medical cannabis products, according to data published in the journal Pain Research and Management.
The administration of CBD is associated with short-term improvements in verbal recall in healthy subjects, according to randomized trial data published in the Journal of Psychiatric Research.
The use of various preparations of whole-plant cannabinoids is associated with perceived benefits among patients with the painful skin disease epidermolysis bullosa (EB), according to survey data published in the Orphanet Journal of Rare Diseases. Epidermolysis bullosa is a rare genetic condition that results in blistering skin.